Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
NASDAQ:HSCS

HeartSciences 3/13/2025 Earnings Report

HeartSciences logo
$3.50 -0.01 (-0.28%)
Closing price 04:00 PM Eastern
Extended Trading
$3.48 -0.02 (-0.43%)
As of 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings HistoryForecast

HeartSciences EPS Results

Actual EPS
-$2.57
Consensus EPS
-$2.53
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A

HeartSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

HeartSciences Announcement Details

Quarter
Date
3/13/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

HeartSciences' next earnings date is estimated for Thursday, September 11, 2025, based on past reporting schedules.

Conference Call Resources

HeartSciences Earnings Headlines

HeartSciences Inc.: HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 25, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65998572-heartsciences-inc-heartsciences-provides-business-update-and-reports-fiscal-2025-financial-results-399.htm
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/24/3121466/0/en/heartsciences-provides-business-update-and-reports-fiscal-2025-financial-results.html
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
August 14 at 2:00 AM  |  Timothy Sykes (Ad)
HeartSciences amends bylaws to add jury trial waiver and ownership threshold - Investing.com
July 3, 2025  |  investing.comhttps://www.investing.com/news/sec-filings/heartsciences-amends-bylaws-to-add-jury-trial-waiver-and-ownership-threshold-93CH-4120181
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/04/3093617/0/en/heartsciences-receives-fda-breakthrough-device-designation-for-myovista-insights-ai-ecg-algorithm-for-detecting-aortic-stenosis.html
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value
June 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/03/3092822/0/en/foundational-us-patent-granted-for-ecg-assessment-of-heart-function-further-expands-heartsciences-patent-portfolio-and-ip-value.html
See More HeartSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HeartSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HeartSciences and other key companies, straight to your email.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View HeartSciences Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles